Aveanna Healthcare refinances $1.325 billion in credit facilities, enhancing liquidity and extending maturities to support growth strategies.
Quiver AI Summary
Aveanna Healthcare Holdings Inc. has successfully closed a refinancing of its first lien credit facility, which includes an $886 million refinancing of existing term loans and an additional $439 million in incremental loans. The company also increased its revolving credit facility from $170.3 million to $250 million, with maturity dates extended to 2032 for the term loans and to 2030 for the revolving facility. The proceeds from the incremental loans were used to fully repay $415 million in second lien term loans, leading to the termination of that facility. CFO Matt Buckhalter noted that this refinancing strengthens the company's balance sheet and operational capacity, while CEO Jeff Shaner highlighted the support from capital partners and the value of Aveanna's national home care platform. Aveanna provides a wide range of healthcare services across 38 states, focusing on both pediatric and adult care.
Potential Positives
- The successful refinancing of the first lien credit facility enhances the company's financial stability by extending maturities and increasing liquidity.
- The repayment and termination of the existing second lien term loans reduce overall debt, thereby strengthening the balance sheet.
- The extension of the revolving credit facility's maximum availability from $170.3 million to $250.0 million provides additional resources for growth and operational flexibility.
- The refinancing is a reflection of the strong operating performance of Aveanna Healthcare, highlighting confidence from financing partners in the company's business strategy and future growth.
Potential Negatives
- The refinancing indicates reliance on debt financing, raising concerns about overall financial health and potential risk during economic downturns.
- Details on the operating performance referenced remain vague, possibly signaling weak underlying metrics that necessitate refinancing.
- The need for a substantial increase in borrowing might suggest preceding liquidity challenges or difficulties in generating operational cash flow.
FAQ
What is Aveanna Healthcare's recent financial announcement?
Aveanna Healthcare announced the closing of its refinanced first lien credit facility worth $1.325 billion.
How does the refinancing affect Aveanna's debt?
The refinancing reduces existing debt and extends the maturity dates of both first and second lien loans.
What are the benefits of the new credit facility?
The facility increases liquidity from $170.3 million to $250 million and strengthens Aveanna's balance sheet.
Who were the lead arrangers for Aveanna's refinancing?
Barclays Bank PLC and Jefferies Finance LLC served as co-lead arrangers for the refinancing.
What services does Aveanna Healthcare provide?
Aveanna offers a range of pediatric and adult healthcare services, including nursing, therapy, and case management.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$AVAH Insider Trading Activity
$AVAH insiders have traded $AVAH stock on the open market 139 times in the past 6 months. Of those trades, 0 have been purchases and 139 have been sales.
Here’s a breakdown of recent trading of $AVAH stock by insiders over the last 6 months:
- PAUL R VIGANO has made 0 purchases and 52 sales selling 2,633,535 shares for an estimated $14,144,311.
- ROBERT M JR WILLIAMS has made 0 purchases and 52 sales selling 2,633,535 shares for an estimated $14,144,311.
- WHITNEY EQUITY PARTNERS VII, LLC J.H. has made 0 purchases and 32 sales selling 2,599,317 shares for an estimated $13,944,525.
- PATRICK A. CUNNINGHAM (Chief Compliance Officer) sold 18,500 shares for an estimated $91,173
- DEBORAH STEWART (SVP, Chief Accounting Officer) sold 15,457 shares for an estimated $85,970
- MATTHEW BUCKHALTER (Chief Financial Officer) sold 11,188 shares for an estimated $63,958
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AVAH Hedge Fund Activity
We have seen 83 institutional investors add shares of $AVAH stock to their portfolio, and 51 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SUMMIT PARTNERS L P added 9,651,423 shares (+inf%) to their portfolio in Q2 2025, for an estimated $50,476,942
- J.H. WHITNEY EQUITY PARTNERS VII, LLC removed 2,598,870 shares (-5.4%) from their portfolio in Q2 2025, for an estimated $13,592,090
- KING STREET CAPITAL MANAGEMENT, L.P. removed 1,710,000 shares (-27.3%) from their portfolio in Q2 2025, for an estimated $8,943,300
- BLACKROCK, INC. added 1,204,110 shares (+30.1%) to their portfolio in Q2 2025, for an estimated $6,297,495
- LITTLEJOHN & CO LLC added 446,736 shares (+5.9%) to their portfolio in Q2 2025, for an estimated $2,336,429
- ROYAL BANK OF CANADA added 433,597 shares (+8365.8%) to their portfolio in Q2 2025, for an estimated $2,267,712
- ALGERT GLOBAL LLC added 343,956 shares (+284.9%) to their portfolio in Q2 2025, for an estimated $1,798,889
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AVAH Analyst Ratings
Wall Street analysts have issued reports on $AVAH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 08/19/2025
- Raymond James issued a "Outperform" rating on 08/11/2025
To track analyst ratings and price targets for $AVAH, check out Quiver Quantitative's $AVAH forecast page.
$AVAH Price Targets
Multiple analysts have issued price targets for $AVAH recently. We have seen 5 analysts offer price targets for $AVAH in the last 6 months, with a median target of $8.0.
Here are some recent targets:
- A.J. Rice from UBS set a target price of $8.0 on 08/19/2025
- Andrew Mok from Barclays set a target price of $9.5 on 08/19/2025
- John Ransom from Raymond James set a target price of $9.0 on 08/11/2025
- Brian Tanquilut from Jefferies set a target price of $6.0 on 07/21/2025
- David Macdonald from Truist Securities set a target price of $5.0 on 07/16/2025
Full Release
ATLANTA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (Nasdaq: AVAH) today announced the closing of its refinanced first lien credit facility. The refinanced credit facility provides for the refinancing of the $886.0 million principal balance of existing first lien term loans, the additional borrowing of $439.0 million in incremental first lien term loans, and the upsize of its revolving credit facility from $170.3 million of maximum availability to $250.0 million of maximum availability. The combined $1.325 billion first lien term loans' maturity dates were extended to 2032, and the revolving credit facility’s maturity date was extended from 2028 to 2030.
Proceeds from the incremental first lien term loans were used to repay in full the existing second lien term loans in the amount of $415.0 million, and as a result, the second lien term loan facility was subsequently terminated.
Barclays Bank PLC and Jeffries Finance LLC served as co-lead arrangers.
“This refinancing marks another important milestone in the company's continued momentum,” said Matt Buckhalter, Chief Financial Officer. “By extending maturities and increasing our available liquidity, including our undrawn revolving facility, we have strengthened our balance sheet and enhanced our ability to execute on our strategy. This progress reflects the strong operating performance we've delivered and the confidence our financing partners have in our business."
“This successful refinancing reflects our operating performance and the proven value of our national home care platform,” said CEO, Jeff Shaner. “We are grateful to our capital partners for their unwavering support of our mission and their commitment to our continued growth and expansion.”
About Aveanna Healthcare
Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 38 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of enteral nutrition and other products to patients. The company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization. For more information, please visit www.aveanna.com.
